| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051858807 |
| P356 | DOI | 10.1007/S13277-012-0634-6 |
| P698 | PubMed publication ID | 23269609 |
| P50 | author | Beatriz Alves | Q78790962 |
| P2093 | author name string | Fernando Luiz Affonso Fonseca | |
| Auro Del Giglio | |||
| Flávia de Sousa Gehrke | |||
| Marcelo Langer Wroclavski | |||
| Pâmela Oliveira Delgado | |||
| Renata Kelly Kuniyoshi | |||
| P2860 | cites work | Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats | Q34530414 |
| Prediction of breast tumor progression by integrity of free circulating DNA in serum. | Q34565015 | ||
| If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells | Q34625589 | ||
| Spontaneous premature chromosome condensation, micronucleus formation, and non-apoptotic cell death in heated HeLa S3 cells. Ultrastructural observations. | Q35795069 | ||
| Overview of cell death signaling pathways | Q36051647 | ||
| DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. | Q43540280 | ||
| Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer | Q46245638 | ||
| Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy | Q47248140 | ||
| Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients | Q48923805 | ||
| Quantification of plasma cell-free DNA in patients with gastric cancer. | Q53534874 | ||
| Increased plasma DNA integrity index in head and neck cancer patients. | Q53588353 | ||
| Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. | Q54688617 | ||
| Role of cell-free plasma DNA as a diagnostic marker for prostate cancer. | Q54710249 | ||
| Increased plasma DNA integrity in cancer patients. | Q54763921 | ||
| Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients | Q81561780 | ||
| Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia | Q85012315 | ||
| P433 | issue | 2 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 983-986 | |
| P577 | publication date | 2012-12-27 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Characterization of cell-free circulating DNA in plasma in patients with prostate cancer | |
| P478 | volume | 34 |
| Q47136367 | Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer |
| Q26750899 | Cell-free circulating tumor DNA in cancer |
| Q45323416 | Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients |
| Q33632125 | Circulating Tumor DNA as Biomarkers for Cancer Detection |
| Q59326857 | Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy |
| Q38165244 | Circulating nucleic acids as biomarkers of prostate cancer. |
| Q49821380 | Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors |
| Q37116462 | Clinical significance of NUCB2 mRNA expression in prostate cancer |
| Q42057245 | Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory setting. |
| Q40581966 | DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. |
| Q38152782 | Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. |
| Q42177585 | Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer's disease: a case report |
| Q53137702 | Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies. |
| Q92494937 | Gene mutation detection of urinary sediment cells for NMIBC early diagnose and prediction of NMIBC relapse after surgery |
| Q86447027 | High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer |
| Q58645659 | Implementing a strategy for on-chip detection of cell-free DNA fragments using GMR sensors: A translational application in cancer diagnostics using ALU elements |
| Q93048458 | Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View |
| Q27010159 | Liquid biopsies: genotyping circulating tumor DNA |
| Q58799160 | Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review) |
| Q55187959 | Liquid biopsy in pancreatic cancer: the beginning of a new era. |
| Q92003217 | Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing |
| Q39243268 | Liquid biopsy: a step forward towards precision medicine in urologic malignancies |
| Q90474937 | Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration |
| Q36392412 | Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation |
| Q38216129 | Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. |
| Q98726002 | Plasma cell-free DNA methylation marks for episodic memory impairment: a pilot twin study |
| Q37367755 | Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer |
| Q37225239 | The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients |
| Q38302944 | Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia |
| Q35813303 | Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers |
| Q43169980 | Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients |
| Q26768470 | When Prostate Cancer Circulates in the Bloodstream |
Search more.